Tatiana Portella

Tatiana Portella

researcher Brazil

Tatiana Portella is a researcher affiliated with the Programa de Computação Científica (Procc) at Fiocruz, Brazil, known for her work on respiratory diseases. Recently, she was in the news discussing the significant increase in cases of severe acute respiratory syndrome (Srag) in the country, emphasizing the role of influenza A and respiratory syncytial virus (VSR) in driving hospitalizations, particularly among vulnerable populations such as the elderly and young children.

Global Media Ratings
Dominance
0.01%
Persistence
1 wks
Reach
832,095
Power
5,914$
Sentiment
8.00
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Brazil 1 8.00 0.36% +10% 211,049,527 832,095 $1,500,000 5,914$
Totals 1 211,049,527 832,095 $1,500,000 5,914$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Brazil Brazil: Tatiana Portella, a researcher from Fiocruz, advises people with flu symptoms to stay at home and rest. 8

O Globo: veja os sinais de alerta com o aumento da infecção 2 semanas do pós-carnaval

Brazil Brazil: Tatiana Portella is a researcher from the Boletim InfoGripe who provided insights on the increase in hospitalizations due to influenza A. 7

O Globo: casos de infecção respiratória grave estão em alta em três estados do Brasil; saiba quais

Brazil Brazil: Tatiana Portella is a researcher from Fiocruz who emphasizes the importance of vaccination for at-risk groups. 8

O Globo: cresce o número de casos graves no Brasil; veja quem pode tomar a vacina

Brazil Brazil: Tatiana Portella is a researcher from Fiocruz who emphasizes the importance of vaccination for at-risk groups. 8

O Globo: cresce o número de casos graves no Brasil; veja quem pode tomar a vacina

Brazil Brazil: Tatiana Portella is a researcher at the Fiocruz and InfoGripe who emphasizes the importance of vaccination against influenza. 9

O Globo: Número de casos de Srag é o maior dos últimos 2 anos, diz InfoGripe